Events

09.02.2016 - 10.02.2016

Wheat – genetic improvement of end use quality

Harpenden (UK)

Many exciting opportunities are available for the genetic improvement of nutritional and processing quality in wheat for direct human consumption. This conference will bring together the best from academic and commercial research in these areas to spell out the state of the art and stimulate discussion for the way ahead in this field. Areas of particular interest will include: nutritional quality and health benefits, (Fe, Zn, Se, fibre, GI); functionality (milling, rheology, baking); mycotoxins, allergy and intolerance and novel traits.
Contact: Association of Applied Biologists

10.02.2016 - 12.02.2016

XV EPI - 15th Iberian Peptide Meeting

Porto (PT)

Peptides offer no less than a whole world of possibilities to Science and Technology. It is under this motto that EPI2016 is expected to bring together from senior scientists to undergraduate students to share their perspectives and experiences in an informal and stimulating atmosphere.
Contact: Faculdade de Ciências do Porto

11.02.2016 - 12.02.2016

Plant Genes and „Omics“: Technology Development

Vienna (A)

The international conference will discuss wide range of modern technologies to discover plant gene, its function and various “Omics” tools and technologies and it will provide leading academy and industry scientists a platform to communicate recent advances and an opportunity to establish multilateral collaborations.
Contact: VISCEA

9th Berlin Conference on IP in Life Sciences - Digital Health Solutions

Media-Partner

12.02.2016

9th Berlin Conference on IP in Life Sciences - Digital Health Solutions

Berlin

The Berlin Conference on IP in Life Sciences has become a must-attend for life sciences decision makers, IP and legal experts, business developers and investors. The upcoming event will explore the potential of digital health technologies for the Life Sciences sector and discuss relevant interfaces of the pharma, biotechnology, medical care and IT sector.
Against the background of an ongoing digital change progress, the conference is designed to provide deep insights into the e-Health market conditions across Europe and beyond. It will highlight the most important next generation IT and personalised medicine solutions which provide pharma, diagnostics and medical care companies with new tools to delevelop treatments and diagnostics, to deliver a better experience to patients, to improve clinical outcomes and to reduce total costs.
Further topics covered during the conference include the impact of IT on Life Science R&D as well as on translational medicine, challenges of big data in the clinical environment as well as the role life science companies are able to play within the new set-up of doctor-to-doctor and doctor-to-patient communication. Furthermore, legal issues regarding the use and the patenting of new digital health products will be discussed.
Contact: Uta Holmer, BIOCOM AG
Phone: +49-30-2649-21-53, Fax: +49-30-2649-21-66
events[at]biocom.de

15.02.2016 - 16.02.2016

RNA Therapeutics

London (UK)

The 2016 RNA Therapeutics conference will hone in on some key developments currently shaping the industry, and putting the spotlight on messenger RNA-based therapeutics.
Contact: SMi Group

17.02.2016 - 19.02.2016

Euromicro International Conference on Parallel Distributed, and Network-Based Processing

Heraklion (GR)

Parallel, Distributed, and Network-Based Processing has undergone impressive changes over recent years. New architectures and applications have rapidly become the central focus of the discipline. These changes are often a result of cross-fertilization of parallel and distributed technologies with other rapidly evolving technologies. It is of paramount importance to review and assess these new developments in comparison with recent research achievements in well-established areas of parallel and distributed computing from industry and the scientific community. PDP 2016 will provide a forum for the presentation of these and other issues through original research presentations and will facilitate the exchange of knowledge and new ideas at the highest technical level.
Contact: Euromicro
office[at]euromicro.org

18.02.2016 - 19.02.2016

6th Crossroads in Biology

Köln

CIB Symposium is organized entirely by graduate students and aims at bringing together
leading scientists from diverse areas of biological research in an interactive environment.
They have already received confirmation of attendance from 10 speakers from
Europe, USA and Australia including Prof. Stefan Hell (Nobel Prize in Chemistry, 2014).
Contact: Universität Köln

21.02.2016 - 23.02.2016

BIOSTEC 2016 – 9th International Joint Conference on Biomedical Engineering Systems and Technologies

Rome (IT)

The purpose of BIOSTEC is to bring together researchers and practitioners, including engineers, biologists, health professionals and informatics/computer scientists, interested in both theoretical advances and applications of information systems, artificial intelligence, signal processing, electronics and other engineering tools in knowledge areas related to biology and medicine. BIOSTEC is composed of five co-located conferences, each specialized in a different knowledge area.
Contact: Institute for Systems and Technologies of Information, Control and Communication (INSTICC)
biostec.secretariat[at]insticc.org

22.02.2016

Pre-clinical Mouse Models for Immuno-Oncology Research

Stockholm (SE)

complementary interactive workshop on the use of pre-clinical mouse models and CRISPR/Cas9 technologies for model generation
Participants will learn:
Rapid and specific mouse model creation using CRISPR/Cas technology.
Approaches for humanizing mice and applications in oncology research.
How leading immuno-oncology scientists overcome the technical challenges of assessing and monitoring tumor response.
Novel techniques for modeling immune checkpoint inhibitors in mouse models.
Contact: The Jackson Laboratory

24.02.2016

Pre-clinical Mouse Models for Immuno-Oncology Research

Copenhagen (DK)

complementary interactive workshop on the use of pre-clinical mouse models and CRISPR/Cas9 technologies for model generation
Participants will learn:
Rapid and specific mouse model creation using CRISPR/Cas technology.
Approaches for humanizing mice and applications in oncology research.
How leading immuno-oncology scientists overcome the technical challenges of assessing and monitoring tumor response.
Novel techniques for modeling immune checkpoint inhibitors in mouse models.
Contact: The Jackson Laboratory

29.02.2016

Pre-clinical Mouse Models for Immuno-Oncology Research

Amsterdam (NL)

complementary interactive workshop on the use of pre-clinical mouse models and CRISPR/Cas9 technologies for model generation
Participants will learn:
Rapid and specific mouse model creation using CRISPR/Cas technology.
Approaches for humanizing mice and applications in oncology research.
How leading immuno-oncology scientists overcome the technical challenges of assessing and monitoring tumor response.
Novel techniques for modeling immune checkpoint inhibitors in mouse models.
Contact: The Jackson Laboratory

02.03.2016

Pre-clinical Mouse Models for Immuno-Oncology Research

Edinburgh (UK)

complementary interactive workshop on the use of pre-clinical mouse models and CRISPR/Cas9 technologies for model generation
Participants will learn:
Rapid and specific mouse model creation using CRISPR/Cas technology.
Approaches for humanizing mice and applications in oncology research.
How leading immuno-oncology scientists overcome the technical challenges of assessing and monitoring tumor response.
Novel techniques for modeling immune checkpoint inhibitors in mouse models.
Contact: The Jackson Laboratory

04.03.2016

Pre-clinical Mouse Models for Immuno-Oncology Research

London (UK)

complementary interactive workshop on the use of pre-clinical mouse models and CRISPR/Cas9 technologies for model generation
Participants will learn:
Rapid and specific mouse model creation using CRISPR/Cas technology.
Approaches for humanizing mice and applications in oncology research.
How leading immuno-oncology scientists overcome the technical challenges of assessing and monitoring tumor response.
Novel techniques for modeling immune checkpoint inhibitors in mouse models.
Contact: The Jackson Laboratory

06.03.2016 - 09.03.2016

ECO-BIO 2016

Rotterdam (NL)

Challenges in building a Sustainable Bioeconomy – This conference will be a first of its kind and will highlight the emergence of the research and innovation field, where we are today and what needs to be done to develop an economically feasible, safe, sustainable, and ecologically friendly biobased future. The conference will be a platform to further the discussions on this highly societal relevant topic.
Contact: BE-Basic Foundation/Elsevier

07.03.2016 - 08.03.2016

EuroPLX 60 – European Pharma License Exchange

Barcelona (ES)

The partnering scope ranges from innovative to generic, from early stage candidates to approved, prescription or OTC drugs, medical devices and companion diagnostics. Delegates determine the focus, displayed and updated hourly on Internet as soon as sufficient data are submitted.
Contact: Dr. Norbert Rau, RauCon
meetyou[at]europlx.com

© 2007-2016 BIOCOM

http://www.european-biotechnology-news.com/service/events.html?cHash=08c22ee578e5863671a6e65d364c419a&events%5Buid%5D=4458&events%5Bmonth%5D=1372629600

Whitepaper

Current issue

All issues

Product of the week

Products

Job Advert

Researchers

As a company at the leading edge of genomics, the focus at Illumina is research and development. We take our employees seriously. From colleagues to career path to meeting professional goals, we help you find opportunities to grow your career. more...

Video

All videos

Stock list

All quotes

TOP

  • EVOCUTIS (UK)0.08 GBP14.29%
  • SERODUS (N)2.60 NOK4.00%
  • SUMMIT (UK)4.03 GBP3.87%

FLOP

  • SWEDISH ORPHAN BIOVITRUM (S)12.45 USD-23.38%
  • BIOTIE THERAPEUTICS (FI)0.14 EUR-22.22%
  • DIAMYD MEDICAL -B- (S)4.30 SEK-12.24%

TOP

  • VERONA PHARMA (UK)3.35 GBP26.4%
  • IXICO (UK)34.00 GBP15.3%
  • WILEX (D)1.95 EUR14.7%

FLOP

  • BIONOR PHARMA (N)0.86 NOK-44.9%
  • PROTHENA PLC (IE)31.71 USD-41.1%
  • PLETHORA (UK)2.62 GBP-36.4%

TOP

  • KARO BIO (S)26.00 SEK3614.3%
  • CHRONTECH PHARMA (S)0.34 SEK3300.0%
  • NICOX (F)7.00 EUR253.5%

FLOP

  • NEUROVIVE PHARMACEUTICAL AB (S)8.70 SEK-85.7%
  • BIOTEST (D)13.24 EUR-85.6%
  • EVOCUTIS (UK)0.08 GBP-71.4%

No liability assumed, Date: 08.02.2016

Events

All Events